Strontium ranelate as a cause of acute renal failure and dress syndrome

Nephrology

Volumn 14, Issue 6, 2009, Pages 624-

  Iyer, Deepa ^a   Buggy, Yvonne ^b   O'Reilly, Katherine ^a   Searle, Martin ^c  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b DRUG SAFETY RESEARCH UNIT   (United Kingdom)

^c CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; PREDNISOLONE; STRONTIUM RANELATE;

ACUTE KIDNEY FAILURE; AGED; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DRESS SYNDROME; DRUG WITHDRAWAL; FEMALE; HUMAN; INTERSTITIAL NEPHRITIS; LABORATORY TEST; LETTER; PRIORITY JOURNAL;

AGED; BONE DENSITY CONSERVATION AGENTS; DRUG HYPERSENSITIVITY; EOSINOPHILIA; EXANTHEMA; FEMALE; HUMANS; KIDNEY FAILURE, ACUTE; ORGANOMETALLIC COMPOUNDS; SYNDROME; THIOPHENES;

EID: 69449103709     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2009.01125.x     Document Type: Letter

References (4)

1. Lee JH. Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs. J. Korean Med. Sci. 2008 23 : 521 525.
2. European Medicines Agency. Questions and answers on the safety of Protelos/Osseor, Nov 2007, Doc. Ref.EMEA/534613/2007.
3. Servier Laboratories Limited. Summary of product characteristics for Strontium Ranelate. January 2008.
4. Shiohara T. The diagnosis of a DRESS Syndrome has been sufficiently establishes on the basis of typical clinical features and viral reactivations. Br. J. Dermatol. 2007 156 : 1083 1084.